Assignee
PANOPTICA INC
US·6 granted patents·9 pending applications·18 citations·filing 2014–2025
Top patents by PatentIndex Score
15 records- 0188US9446026B2Ocular formulations for drug-delivery to the posterior segment of the eyePANOPTICA INC·Filed 2014·Granted Sep 20, 2016·8 cites·11 claims
- 0287US10183014B2Ocular formulations for drug-delivery and protection of the anterior segment of the eyePANOPTICA INC·Filed 2017·Granted Jan 22, 2019·2 cites·21 claims
- 0387US9814702B2Ocular formulations for drug-delivery and protection of the anterior segment of the eyePANOPTICA INC·Filed 2015·Granted Nov 14, 2017·2 cites·18 claims
- 0487US9623011B2Ocular formulations for drug-delivery and protection of the anterior segment of the eyePANOPTICA INC·Filed 2016·Granted Apr 18, 2017·2 cites·12 claims
- 0587US2024325357A1Ocular formulations for drug-delivery to the posterior segment of the eyePANOPTICA INC·Filed 2024·Application pending·0 cites
- 0685US2024277674A1Ocular formulations for drug-delivery and protection of the anterior segment of the eyePANOPTICA INC·Filed 2023·Application pending·0 cites
- 0783US10307404B1Ocular formulations for drug-delivery to the posterior segment of the eyePANOPTICA INC·Filed 2018·Granted Jun 4, 2019·2 cites·37 claims
- 0878US10092549B2Ocular formulations for drug-delivery to the posterior segment of the eyePANOPTICA INC·Filed 2014·Granted Oct 9, 2018·2 cites·20 claims
- 0977US2026048039A1Ocular formulations for drug-delivery and protection of the anterior segment of the eyePANOPTICA INC·Filed 2025·Application pending·0 cites
- 1074US2021196690A1Ocular formulations for drug-delivery to the posterior segment of the eyePANOPTICA INC·Filed 2021·Application pending·0 cites
- 1172US2021275501A1Ocular formulations for drug-delivery and protection of the anterior segment of the eyePANOPTICA INC·Filed 2020·Application pending·0 cites
- 1267US2019247368A1Ocular formulations for drug-delivery to the posterior segment of the eyePANOPTICA INC·Filed 2019·Application pending·0 cites
- 1367US2019240201A1Ocular formulations for drug-delivery to the posterior segment of the eyePANOPTICA INC·Filed 2019·Application pending·0 cites
- 1465US2019314343A1Ocular formulations for drug-delivery and protection of the anterior segment of the eyePANOPTICA INC·Filed 2018·Application pending·0 cites
- 1560US2016354349A1Ocular formulations for drug-delivery to the posterior segment of the eyePANOPTICA INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →